What is HeartcoR Solutions?
HeartcoR Solutions operates as a premier global ECG core lab, providing critical support for safety studies within the life sciences industry. By integrating expert ECG recording, certified technician analysis, and validated data set delivery, the company serves as a vital partner for pharmaceutical firms, medical device manufacturers, and contract research organizations (CROs). Their service model is defined by a deep bench of electrophysiologists and ECG-certified technicians, ensuring that complex clinical trial protocols are met with precision. Through the deployment of advanced recording hardware and customized reporting, HeartcoR mitigates risk in drug and device development, maintaining a reputation for high-touch service and rigorous adherence to regulatory standards.
How much funding has HeartcoR Solutions raised?
HeartcoR Solutions has raised a total of $319K across 1 funding round:
Debt
$319K
Debt (2021): $319K with participation from PPP
Key Investors in HeartcoR Solutions
PPP
Public-Private Partnership
What's next for HeartcoR Solutions?
With this late-stage financing, HeartcoR Solutions is positioned to accelerate its technological roadmap and expand its footprint in the global clinical trial market. The capital will likely be deployed to enhance their proprietary data analysis platforms and increase the capacity of their technician network to handle larger, more complex multi-center trials. As the regulatory environment for cardiac safety becomes increasingly stringent, HeartcoR's ability to provide validated, audit-ready data sets will be a key differentiator. The firm is expected to leverage this investment to deepen its integration with CRO workflows, further cementing its role as an essential component of the medical innovation pipeline.
See full HeartcoR Solutions company page
